Antoni Nabzdyk shared a bearish thesis on LyondellBasell Industries N.V. (LYB) in a recent article, citing concerns about the company’s exposure to commodity prices and weak pricing power. LYB’s stock was trading at $48.99 as of November 28th, with trailing and forward P/E ratios of 104.96 and 12.89 respectively. The company’s technology segment, which generates 50% EBITDA margins, stands out as a bright spot, but other segments have struggled with negative or low margins. LYB’s high debt levels relative to cash reserves add risk to its operations, making it a high-risk proposition for investors.

Scholar Rock (SRRK) saw a 29% increase in its stock price as its drug candidate progresses, showing positive momentum in the market.

In contrast, a previously bullish thesis on Eastman Chemical Company (EMN) did not play out as expected, leading to a significant decline in the stock price. Antoni Nabzdyk highlights LYB’s challenges with commodity cyclicality and pricing power, signaling a “SELL” stance based on its operational and strategic profile.

Read more at Yahoo Finance: LyondellBasell Industries N.V. (LYB): A Bear Case Theory